The effectiveness of insulin for Alzheimer’s disease may be explained from the viewpoint of metabolic stress (Wakabayashi et al., 2019) as follows: metabolic stress causes the onset of insulin resistance and lowers the removal rate of amyloid β proteins from the brain, thereby promoting their accumulation. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.